Amgen Repurchases Astellas’ Stakes in Amgen Astellas JV to Strengthen its Footprints in Japan

 Amgen Repurchases Astellas’ Stakes in Amgen Astellas JV to Strengthen its Footprints in Japan

Amgen Repurchases Astellas’ Stakes in Amgen Astellas JV to Strengthen its Footprints in Japan

Shots:

  • Amgen has consummated the purchase of Astellas’49% shares of AABP, a JV between Amgen and Astellas established in 2013
  • AABP now serves as a wholly-owned Amgen affiliate in Japan while the Amgen renamed it as Amgen KK, enabling the company to bolster its presence in Japan
  • Amgen KK will continue the marketing of therapies targeting CV, cancer, osteoporosis and will bring Amgen’s global pipeline to Japanese patients. Additionally, in 2019, Amgen has invested ~$4B in research and development to advance new therapies across all stages of its pipeline

Click here ­to­ read full press release/ article | Ref: Amgen | Image: Behance

Tuba Khan

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on tuba@pharmashots.com

Related post